Answers are grounded in this paper and cite their sources.
Background: Mowat–Wilson syndrome (MWS) is a rare neurodevelopmental disorder caused by heterozygous pathogenic variants or deletions involving ZEB2. Its core clinical features include distinctive craniofacial dysmorphism, severe developmental delay or intellectual disability, absent or markedly impaired speech, epilepsy, growth deficiency, and multiple congenital anomalies. Craniosynostosis has been reported only rarely and is not considered a typical manifestation of the syndrome. This study aimed to characterize the clinical and molecular findings of MWS-associated craniosynostosis through a systematic review of individual-level data. Additionally, we present two patients with pathogenic ZEB2 variants, including one with a novel de novo frameshift variant and complex craniosynostosis. Methods: A systematic literature review was conducted in accordance with the PRISMA-IPD statement. PubMed and Scopus were systematically searched from database inception to 4 September 2026 for reports of molecularly confirmed MWS associated with craniosynostosis. Eligible reports providing individual-level clinical and molecular data were selected, and relevant data were independently extracted by two reviewers and summarized descriptively. Results: The systematic review identified three studies reporting four molecularly confirmed patients with MWS and craniosynostosis. Isolated right unicoronal craniosynostosis was reported in three patients (3/4), while one patient (1/4) had combined right coronal and metopic synostosis. The reported molecular alterations included ZEB2 frameshift variants and a multigene deletion involving ZEB2, with no apparent association between variant type or location and the pattern of craniosynostosis, although the number of cases was limited. In addition, we describe a patient with a novel de novo ZEB2 frameshift variant, c.2730_2802del, p.(Met910IlefsTer43), and complex left coronal and sagittal craniosynostosis, representing the first reported case of MWS with sagittal suture involvement. A second patient carried a pathogenic de novo ZEB2 missense variant, p.(His1073Arg), and exhibited a classical MWS phenotype without craniosynostosis. Conclusions: This systematic review, together with the newly reported case expands the molecular spectrum of ZEB2-related Mowat–Wilson syndrome and supports craniosynostosis as an uncommon but clinically relevant manifestation. The findings in Patient 2 further indicate that pathogenic missense ZEB2 variants may also be associated with a classical multisystem MWS phenotype. Although the available evidence does not support classifying ZEB2 as a classical craniosynostosis gene, careful assessment of cranial shape and signs of premature suture fusion appears warranted in affected individuals.
No takes yet. Share an insight, caveat, or question.
Wnuk-Kłosińska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: